Dr. Reddy’s Hopes U.S. FDA Visit Will Clear Mexico Production Facility
This article was originally published in PharmAsia News
Executive Summary
India-based Dr. Reddy’s Laboratories expects a visit by U.S. FDA inspectors at its production facility in Mexico by the end of March, a visit it hopes will lead to release of its products into the U.S.